Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis

Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Pharmacological Research - Volume 131, May 2018, Pages 244-254

Sarah Cargnin, Gloria Ravegnini, Simona Soverini, Sabrina Angelini, Salvatore Terrazzino,